These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30349477)

  • 21. Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.
    Caccavelli L; Feron F; Morange I; Rouer E; Benarous R; Dewailly D; Jaquet P; Kordon C; Enjalbert A
    Neuroendocrinology; 1994 Sep; 60(3):314-22. PubMed ID: 7969790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines.
    Efferth T; Sauerbrey A; Halatsch ME; Ross DD; Gebhart E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):56-67. PubMed ID: 12616342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells.
    Ochwang'i DO; Kimwele CN; Oduma JA; Gathumbi PK; Kiama SG; Efferth T
    J Ethnopharmacol; 2018 Apr; 215():233-240. PubMed ID: 29309859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.
    Tajima Y; Nakagawa H; Tamura A; Kadioglu O; Satake K; Mitani Y; Murase H; Regasini LO; Bolzani Vda S; Ishikawa T; Fricker G; Efferth T
    Phytomedicine; 2014 Feb; 21(3):323-32. PubMed ID: 24135452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids.
    Mrusek M; Seo EJ; Greten HJ; Simon M; Efferth T
    Invest New Drugs; 2015 Feb; 33(1):32-44. PubMed ID: 25342140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells.
    Saeed ME; Abdelgadir H; Sugimoto Y; Khalid HE; Efferth T
    J Ethnopharmacol; 2015 Nov; 174():644-58. PubMed ID: 26165828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines.
    Kuete V; Tchinda CF; Mambe FT; Beng VP; Efferth T
    BMC Complement Altern Med; 2016 Aug; 16():267. PubMed ID: 27484842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity of ungeremine towards multi-factorial drug resistant cancer cells and induction of apoptosis, ferroptosis, necroptosis and autophagy.
    Mbaveng AT; Bitchagno GTM; Kuete V; Tane P; Efferth T
    Phytomedicine; 2019 Jul; 60():152832. PubMed ID: 31031043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells.
    Issa ME; Hall SR; Dupuis SN; Graham CL; Jakeman DL; Goralski KB
    Anticancer Drugs; 2014 Mar; 25(3):255-69. PubMed ID: 24231527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
    Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Teng QX; Chen ZS; Kong D; Yang DH
    Front Pharmacol; 2018; 9():1236. PubMed ID: 30425643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
    Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
    Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines.
    García MG; Alaniz L; Lopes EC; Blanco G; Hajos SE; Alvarez E
    Leuk Res; 2005 Dec; 29(12):1425-34. PubMed ID: 15982733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas.
    Caccavelli L; Morange-Ramos I; Kordon C; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1996 Oct; 8(10):737-46. PubMed ID: 8910802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to bromocriptine in prolactinomas.
    Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.
    Wu CP; Hsiao SH; Huang YH; Hung LC; Yu YJ; Chang YT; Hung TH; Wu YS
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.